The US FDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting for Thursday, March 9, 2017 to discuss and make recommendations on the selection of strains to be included in the influenza virus vaccines for the 2017-2018 U.S. influenza season.
See the SAC Tracker report